{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-202430","form_type":"8-K","ticker":"ANTX","cik":"0001880438","company_name":"AN2 Therapeutics, Inc.","filed_at":"2024-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.090284+00:00","generated_at":"2026-05-31T08:43:43.356770+00:00","sec_items":["1.01","3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"AN2 Therapeutics adopts limited-duration stockholder rights plan after BML accumulates 19.3% stake","bullets":["Rights plan triggered by rapid accumulation of 19.3% of ANTX common stock by BML Investment Partners, as disclosed in Aug. 14, 2024 13G/A filing.","One preferred stock purchase right distributed per common share held on Aug. 29, 2024; exercise price $6.50 per one-thousandth of Series A Preferred.","Rights become exercisable if a person or group acquires 20% or more of common stock (including synthetic ownership).","Rights expire Aug. 15, 2025, unless earlier redeemed ($0.01 per right) or exchanged by Board.","Plan designed to protect all stockholders and prevent coercive takeover tactics without paying a control premium."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-202430","json":"https://secwatch.observer/filing/0001193125-24-202430.json","markdown":"https://secwatch.observer/filing/0001193125-24-202430.md","text":"https://secwatch.observer/filing/0001193125-24-202430.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1880438/000119312524202430/0001193125-24-202430-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1880438/000119312524202430/d879523d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:43:43.356770+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}